feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Sports / Cancer Battle Over: Nikola Topic Back Training with Thunder

Cancer Battle Over: Nikola Topic Back Training with Thunder

9 Jan

•

Summary

  • Nikola Topic completed chemotherapy for testicular cancer.
  • Topic was selected 12th overall in the 2024 NBA Draft.
  • He missed his entire rookie season due to injury and illness.
Cancer Battle Over: Nikola Topic Back Training with Thunder

Oklahoma City Thunder prospect Nikola Topic has successfully completed his chemotherapy treatment for testicular cancer. The 20-year-old, who was the 12th overall selection in the 2024 NBA Draft, had previously missed his entire rookie season due to an ACL tear. Just as he was nearing a return from that injury, he was diagnosed with cancer, necessitating further time away from the court.

With his cancer treatment concluded, Topic is now set to resume training with the Thunder. His return to practice offers a significant boost as the team battles for a top seed in the Western Conference. While a specific timeline for his NBA debut has not yet been established, there is potential for him to be assigned to the Oklahoma City Blue, the team's G-League affiliate, as part of his reintegration process.

The Thunder organization and its fanbase are looking forward to the potential impact Topic can bring to an already deep roster. His journey through injury and illness to this point highlights his resilience. As Oklahoma City continues its push for postseason success, the imminent possibility of Topic joining the active roster adds another layer of optimism for the team's prospects.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Nikola Topic recently completed chemotherapy for testicular cancer and is now returning to training with the Thunder.
A timetable for Nikola Topic's NBA debut has not yet been released, but he has returned to training.
No, Nikola Topic missed his entire rookie season due to an ACL tear and a subsequent cancer diagnosis.

Read more news on

Sportsside-arrowOklahoma City Thunderside-arrow
trending

Roblox CEO sells stock

trending

Tigers linked to Bassitt, Giolito

trending

Wawrinka gets Australian Open wildcard

trending

Ozark Trail stoves recalled

trending

Switzerland reaches United Cup final

trending

Hurkacz leads Poland to title

trending

Medvedev credits Aussie coach revival

trending

Adithya Ashok: New Zealand Squad

You may also like

Thunder Reign: Top of West, Aiming for Repeat Title

22 Dec, 2025 • 91 reads

article image

Thunder Prospect Nikola Topic Battles Cancer

19 Dec, 2025 • 36 reads

article image

Thunder Chasing NBA History: Best Ever?

14 Dec, 2025 • 169 reads

article image

Chet Holmgren Signs $250M Deal, Thunder Lock Down Future

11 Dec, 2025 • 219 reads

article image

Cavs Fined $100K for Resting Stars Together

19 Nov, 2025 • 130 reads

article image